- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 56.65M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $25.06M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $25.19M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.17B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.29B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.64B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.63B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $789.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $821.04M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.08B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.12B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.42B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.43B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.72B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.75B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 58.93M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $120.59M |
| Capex | Q1 2025 · Mar 31, 2024 | $6.75M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $129.92M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.97 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $198.45M |
| Net Income | Q1 2025 · Mar 31, 2024 | $116.24M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $110.53M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $834.33M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.17B |